chr17-50089616-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000514834.1(ITGA3):​n.661C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0924 in 234,606 control chromosomes in the GnomAD database, including 1,764 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.089 ( 1006 hom., cov: 31)
Exomes 𝑓: 0.098 ( 758 hom. )

Consequence

ITGA3
ENST00000514834.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.20

Publications

4 publications found
Variant links:
Genes affected
ITGA3 (HGNC:6139): (integrin subunit alpha 3) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function as cell surface adhesion molecules. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 3 subunit. This subunit joins with a beta 1 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. Expression of this gene may be correlated with breast cancer metastasis. [provided by RefSeq, Oct 2015]
ITGA3 Gene-Disease associations (from GenCC):
  • epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.31 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA3NM_002204.4 linkc.*538C>T 3_prime_UTR_variant Exon 26 of 26 ENST00000320031.13 NP_002195.1 P26006-2A0A140VJM0
ITGA3XM_005257308.3 linkc.*538C>T 3_prime_UTR_variant Exon 24 of 24 XP_005257365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA3ENST00000320031.13 linkc.*538C>T 3_prime_UTR_variant Exon 26 of 26 1 NM_002204.4 ENSP00000315190.8 P26006-2

Frequencies

GnomAD3 genomes
AF:
0.0892
AC:
13564
AN:
151990
Hom.:
1004
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0254
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.187
Gnomad ASJ
AF:
0.0939
Gnomad EAS
AF:
0.323
Gnomad SAS
AF:
0.247
Gnomad FIN
AF:
0.0905
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0765
Gnomad OTH
AF:
0.106
GnomAD4 exome
AF:
0.0983
AC:
8107
AN:
82498
Hom.:
758
Cov.:
0
AF XY:
0.102
AC XY:
4319
AN XY:
42542
show subpopulations
African (AFR)
AF:
0.0197
AC:
78
AN:
3962
American (AMR)
AF:
0.178
AC:
877
AN:
4940
Ashkenazi Jewish (ASJ)
AF:
0.0831
AC:
230
AN:
2768
East Asian (EAS)
AF:
0.312
AC:
1852
AN:
5940
South Asian (SAS)
AF:
0.194
AC:
1088
AN:
5620
European-Finnish (FIN)
AF:
0.0751
AC:
283
AN:
3766
Middle Eastern (MID)
AF:
0.0684
AC:
26
AN:
380
European-Non Finnish (NFE)
AF:
0.0640
AC:
3213
AN:
50202
Other (OTH)
AF:
0.0935
AC:
460
AN:
4920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
340
680
1019
1359
1699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0893
AC:
13580
AN:
152108
Hom.:
1006
Cov.:
31
AF XY:
0.0964
AC XY:
7169
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0254
AC:
1056
AN:
41524
American (AMR)
AF:
0.188
AC:
2863
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.0939
AC:
326
AN:
3470
East Asian (EAS)
AF:
0.323
AC:
1656
AN:
5126
South Asian (SAS)
AF:
0.245
AC:
1181
AN:
4812
European-Finnish (FIN)
AF:
0.0905
AC:
958
AN:
10588
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0765
AC:
5203
AN:
68004
Other (OTH)
AF:
0.111
AC:
234
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
583
1165
1748
2330
2913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0821
Hom.:
851
Bravo
AF:
0.0911
Asia WGS
AF:
0.276
AC:
958
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
10
DANN
Benign
0.84
PhyloP100
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744538; hg19: chr17-48166980; COSMIC: COSV50323327; COSMIC: COSV50323327; API